nad has been researched along with 5-(tetradecyloxy)-2-furancarboxylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muir, LA; White, LS; Yang, YT | 1 |
| Bililign, T; El Meskini, R; Han, WF; Kim, EK; Kuhajda, FP; Landree, LE; Medghalchi, SM; Pinn, ML; Ronnett, GV; Thupari, JN; Townsend, CA; Vadlamudi, A; Zhou, W | 1 |
2 other study(ies) available for nad and 5-(tetradecyloxy)-2-furancarboxylic acid
| Article | Year |
|---|---|
Lactate metabolism and cytosolic NADH reducing equivalents in ovine adipocytes.
Topics: 2,4-Dinitrophenol; Adipose Tissue; Aminooxyacetic Acid; Animals; Cytosol; Dinitrophenols; Fatty Acids; Furans; Hypolipidemic Agents; Lactates; Lactic Acid; Male; NAD; Sheep | 1982 |
Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Topics: Amino Acid Sequence; AMP-Activated Protein Kinases; Animals; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Fatty Acid Synthases; Fatty Acids; Female; Furans; Glucose; Humans; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Multienzyme Complexes; NAD; Ovarian Neoplasms; Oxidation-Reduction; Protein Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2007 |